Select a medication above to begin.
Gardasil 9
human papillomavirus 9-valent vaccine (recombinant) (HPV)
Adult Dosing .
Dosage forms: INJ
HPV-related cancer, dysplastic lesion, and genital wart prevention
- [18-45 yo]
- Dose: 0.5 mL IM x1 at mo 0, mo 1-2, and mo 6 for 3 total doses; Info: give to pts 27-45 yo based on shared clinical decision-making; repeat dose if <4wk between 1st and 2nd dose, <12wk between 2nd and 3rd dose, or <5mo between 1st and 3rd dose; search 'immunization' for epocrates Adult Immunization decision tool incl. links to CDC/ACIP schedules
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [no adjustment]
Peds Dosing .
- Dosage forms: INJ
HPV-related cancer, dysplastic lesion, and genital wart prevention
- [9-14 yo, immunocompetent pts]
- Dose: 0.5 mL IM x1 at mo 0 and mo 6-12 for 2 total doses; Info: give a 3rd dose at least 4mo after 2nd dose if 2nd dose given <5mo after 1st dose; start series at 9 yo if sexual abuse or assault hx; search 'immunization' for epocrates Child/Adolescent Immunization decision tool incl. links to CDC/ACIP schedules
- [9-14 yo, immunocompromised pts]
- Dose: 0.5 mL IM x1 at mo 0, mo 1-2, and mo 6 for 3 total doses; Info: repeat dose if <4wk between 1st and 2nd dose, <12wk between 2nd and 3rd dose, or <5mo between 1st and 3rd dose; start series at 9 yo if sexual abuse or assault hx; search 'immunization' for epocrates Child/Adolescent Immunization decision tool incl. links to CDC/ACIP schedules
- [15-17 yo]
- Dose: 0.5 mL IM x1 at mo 0, mo 1-2, and mo 6 for 3 total doses; Info: repeat dose if <4wk between 1st and 2nd dose, <12wk between 2nd and 3rd dose, or <5mo between 1st and 3rd dose; search 'immunization' for epocrates Child/Adolescent Immunization decision tool incl. links to CDC/ACIP schedules
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [no adjustment]